Study Stopped
Recruitment issue
Impact of a Dynamic Dressing in the Management of Unoperated Hallux Valgus (DYNHALLUX)
DYNHALLUX
1 other identifier
interventional
6
1 country
1
Brief Summary
Hallux Valgus (HV) is a lateral deviation of the big toe. HV is a deformity of the forefoot centered on the 1st radius (1st metatarsal and big toe). This deformation is characterized by:
- a big toe (hallux) deviated outwards (valgus greater than 12 °)
- a first metatarsal moved medially (varus) (angle M1 / M2\> 10 °). We also note the existence of an exostosis formed by the apex of the angle between the 1st metatarsal deviated inwards and the big toe deported outwards. This exostosis corresponds to the head of the 1st metatarsal. In addition to the pain and the unaesthetic nature induced by this deviation, the modifications of the skeletal axes of the foot cause disorders of its function but also of the joints of the lower limb during standing, walking and running. Axis defects of the lower limbs in varum or valgum also cause deformities in the rearfoot, midfoot and forefoot. There is no non-surgical curative treatment for this deformity. Different conservative treatment options have been offered for first-line treatment, including different types of physiotherapy, wearing rigid insoles or splints. Wearing rigid insoles is indicated to "counter" the valgic pressure, thereby reducing pain and high plantar pressure, in patients with HV. Their hardness, expressed in SHORE units, must be greater than 65. By countering the valgic pressure (rearfoot and midfoot), the rigid soles make it possible to contain the development of deformation and stabilize the axis of the first spoke. The speed of hallux deformation is therefore greatly reduced if the soles are worn diligently. But there is little or no impact on the correction of the deformity, but it is stabilized as it is without rapid and major worsening. Indeed, soles with a hardness greater than or equal to 65 SHORE make it possible to avoid the valgum of the hindfoot and midfoot under load and when walking. Wearing a dynamic splint was studied in a recently published prospective randomized study conducted between 2011 and 2013. This study, concluding that the dynamic splint is not effective in reducing the angle of deformation of the HV, nevertheless shows the reduction in pain during walking and running. The limits of the study lie in the pace of wearing the splint, left to the discretion of patients, during their rest period, and in the duration of the operation, which is not precisely described.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2021
CompletedFirst Posted
Study publicly available on registry
February 1, 2021
CompletedStudy Start
First participant enrolled
April 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2022
CompletedJuly 22, 2022
July 1, 2022
9 months
January 26, 2021
July 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline M1 / P1 angle at day 75 measured by weightbearing foot radiograph
M1 / P1 angle measured before and after intervention
radiograph between day 0 less than 6 months and day 0 and radiograph at day 75
Secondary Outcomes (8)
Variation of the M1 / M2 angle measured by weightbearing foot radiograph
radiograph between day 0 less than 6 months and day 0 and radiograph at day 75
Variation of the M1 / P1 and M1/M2 angle measured by weightbearing foot radiograph at long time
radiograph at day 75 and at month 6 and month 12
12-month surgery rate
month 12
Quality of life measured by the American Orthopedic Foot and Ankle Society score
day 0, day 75, month 6 and month 12
Quality of life measured by the Foot Function Index score
day 0, day 75, month 6 and month 12
- +3 more secondary outcomes
Study Arms (2)
Control arm
NO INTERVENTIONwearing made-to-measure soles with SHORE greater than or equal to 65 (standard of care)
Interventional arm
EXPERIMENTALwearing made-to-measure soles with SHORE greater than or equal to 65 + dynamic dressing of the joint
Interventions
Dynamic dressing is made by bandages of the foot with gauze pad, stretchable adhesive tape and elastic compression band
Eligibility Criteria
You may qualify if:
- hallux valgus on at least one foot theoretically requiring surgical management within 12 months
- reducible hallux valgus
- beneficiary of a social security scheme
- informed of the study and signed informed consent form
You may not qualify if:
- History of hallux valgus correction surgery on the affected foot
- History of traumatic lesion of the M1-P1 metatarsophalangeal joint of the affected foot
- Skin pathology limiting or contraindicating the possibility of dressings according to the judgment of the investigator (eg dyshidrotic eczema, psoriasis or other problematic skin damage located in the foot)
- Acute bursitis
- Clinical and / or radiological stage 1 or more osteoarthritis according to the criteria of Kellgren and Lawrence
- Non-stabilized diabetes and / or diabetes with micro / macrovascular complications
- Patients with neuropathy
- History of gout
- History of rheumatic pathology
- Obliterating arteriopathy of the lower limbs of stage II or more according to the classification of Leriche and Fontaine
- Pregnant woman
- Patients under tutorship or curatorship
- Patients under legal protection
- Patients who do not understand French
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Annecy Genevois
Metz-Tessy, 74374, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guy Allamel, PhD
CH Annecy Genevois
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2021
First Posted
February 1, 2021
Study Start
April 22, 2021
Primary Completion
January 25, 2022
Study Completion
January 25, 2022
Last Updated
July 22, 2022
Record last verified: 2022-07